Randall T. Espinoza, MD, MPH

Garvey Institute Center for Neuromodulation, University of Washington School of Medicine, Seattle, Washington

  • 3Articles
  • 6.6KReads1
  • 2023–2025Active
  • 6Collaborators
  • 10Citations2

About

Randall T. Espinoza, MD, MPH, is affiliated with the Garvey Institute Center for Neuromodulation at the University of Washington School of Medicine. His publications from 2023 to 2025 focus on clinical topics including electroconvulsive therapy, catatonia, delirium, and major depressive disorder. His work addresses treatment modalities such as electroconvulsive therapy and ketamine in managing treatment-resistant depression, as well as the characterization of delirium subtypes related to COVID-19. He frequently collaborates with co-authors including Aaron Kaufman, Charles H. Kellner, and Roger S. McIntyre.

Publications

PCC
Knowledge of ECT for Catatonia
JCP
Ketamine vs ECT in the Management of Treatment-Resistant Depression: Do We Need More Data?
JCP
COVID-19 Delirium and Motoric Subtypes: Improving Outcomes

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.